1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line

Journal of Neuroscience Research

Volumn 46, Issue 5, 1996, Pages 540-550

  Baudet, Christel ^a   Chevalier, Guillemette ^a   Chassevent, Agnès ^b   Canova, Cécile ^a   Filmon, Robert ^c   Larra, Francis ^b   Brachet, Philippe ^a   Wion, Didier ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b CENTRE PAUL PAPIN   (France)

^c Universite d'Angers   (France)

Author keywords

apoptosis; calcitriol; glioma; programmed cell death; vitamin D

Indexed keywords

CALCITRIOL; CYCLOHEXIMIDE; DNA FRAGMENT; ENDOTHELIAL CELL GROWTH FACTOR; FORSKOLIN; GENISTEIN; INTERLEUKIN 6; MESSENGER RNA; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; SECOSTEROID; STEROID HORMONE; VITAMIN D; VITAMIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA CELL; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CALCITRIOL; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; FORSKOLIN; GENISTEIN; GLIOMA; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOFLAVONES; LYMPHOKINES; NERVE TISSUE PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029845035     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19961201)46:5<540::AID-JNR3>3.0.CO;2-J     Document Type: Article

References (75)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y (1987): Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
2. Auffray C, Rougeon F (1980): Purification of mouse immunoglobulin heavy chain messenger RNAs for total myeloma tumor RNA. Eur J Biochem 107:303-314.
3. Benda P, Lightbody J, Sato G, Levine L, Sweet W (1969): Differentiated rat glial cell strain in tissue culture. Science 161:370-371.
4. Bikle DD (1992): Vitamin D: new actions, new analogs, new therapeutic potential. Endocrine Rev 13:765-784.
5. Bower M, Colston KW, Stein RC, Medley A, Gazet JC, Ford HT, Coombes RC (1991): Topical calcipotriol treatment in advanced breast cancer. Lancet 337:701-702.
6. Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TL, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, Kastan MB, Fornace AJ (1994): Characterization of human gadd45, a p53-regulated protein. J Biol Chem 269:32672-32677.
7. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993): Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
8. Collins RJ, Harmon BV, Gobé GC, Kerr JFR (1992): Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat 61:451-453.
9. Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC (1992): EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273-2280.
10. Compton MM (1992): A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev 11:105-119.
11. Criscuolo GR (1993): The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. Yale J Biol Med 66:277-314.
12. Davies DL, Vernadakis A (1986): Response in astrocytic C6 glioma cells to ethanol and dibutyryl cyclic AMP. Dev Brain Res 24: 253-260.
13. DeLuca HF, Ostrem V (1986): The relationship between the vitamin D system and cancer. Adv Exp Med Biol 206:413-419.
14. Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton JM (1989): 1,25-dihydroxyvitamin D3 regulation of human cancer cell replication. Proc Soc Exp Biol Med 191:221-226.
15. Evan GI, Wyllie AH, Gilbert CO, Littlewood TO, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992): Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
16. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C (1992): Wild-type p53 activates transcription in vitro. Nature 358:83-86.
17. Fornace AJ, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoloi J, Holbrook NJ (1989): Mammalian genes coor- dinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9:4196-4203.
18. Fort P, Piechaczyk M, Sabrouty S, Dani C, Jeanteur P, Blanchard J-M (1985): Various rat adult tissues express only one major mRNA species from the glutaraldehyde-3 phosphate dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442.
19. Frankel RH, Bayona W, Koslow M, Newcomb EW (1992): p53 mutations in human gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433.
20. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991): Interleukin-6 improves the survival of mesencephalic catecholaminergic and septa] cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40:445-452.
21. Hermeking H, Eick D (1994): Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093.
22. Hoffman B, Liebermann DA (1994): Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9:1807-1812.
23. Jones G, Calverley MJ (1993): A dialogue on analogues. Newer vitamin D drugs for use in bone disease, psoriasis, and cancer. Trends Endocrinol Metab 4:297-302.
24. Jordan JP, Hand CM, Markowitz RS, Black P (1992): Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J Neuro-Oncol 14:19-35.
25. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ (1992): A mammalian cell cycle checkpoint pathway utilizing p53 and gadd45 is defective in Ataxia-Telangiectasia. Cell 71:587-597.
26. Kerr JFR, Wyllie AH, Currie AR (1972): Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
27. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, Ferrara N (1993): Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-843.
28. Kliewer SA, Umesono K, Mangelsdorf D, Evans RM (1992): Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449.
29. Levitzki A, Gilon C (1991): Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol Sci 21:171-174.
30. Liu CG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA (1994): Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284.
31. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993): p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
32. MacDonald PN, Dowd DR, Haussler MR (1994): New insight into the structure and functions of the vitamin D receptor. Sem Nephrol 14:101-118.
33. Magrassi L, Bono F, Milanesi G, Butti G (1992): Vitamin D receptor expression in human brain tumors. J Neurosurg Sci 36:27-30.
34. Mallorga P, Tallman JF, Fishman PH (1981): Differences in the β-adrenergic responsiveness between high and low passage rat glioma C6 cells. Biochem Biophys Acta 678:221-229.
35. Martin SJ, Green DR, Cotter TG (1994): Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 19:26-30.
36. Messens J, Siegers H (1992): Synthesis of glial fibrillary acidic protein in rat C6 glioma in chemically defined medium: cyclic AMP- dependent tianscriptional and translational regulation. J Neurochem 58:2071-2080.
37. Naveilhan P, Berger F, Haddad K, Barbot N, Benabid AL, Brachet P, Wion D (1994): Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci Res 37:271-277.
38. Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M (1994a): 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. NeuroReport 6:124-126.
39. Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, DeLuca HF, Brachet P (1994b): 1,25-(OH)2D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol Brain Res 24:70-76.
40. Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabédian M (1994c): Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res 38:214-220.
41. Norman AW, Roth J, Orci L (1991): The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocrin Rev 3:331-366.
42. Papathanasiou MA, Kerr N, Robbins JH, McBride OW, Alamo I, Barett SF, Hickson I, Fornace AJ (1991): Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol 11:1009-1016.
43. Perry VH, Gordon S (1991): Macrophages and the nervous system. Int Rev Cytol 125:203-244.
44. Plate KH, Brier G, Weich HA, Riau W (1992): Vascular endothelial growth factor is a potential tumor angiogenesis factor in human glioma in vivo. Nature 359:845-848.
45. Plate KH, Breier G, Millauer B, Ulltich A, Risau W (1993): Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827.
46. Plate KH, Brier G, Weich HA, Mennel HD, Risau W (1994): Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529.
47. Pols HA, Birkenhager JC, Foenkens JA, Van Leeuwen JP (1990): Vitamin D: a modulator of cell proliferation and differentiation. J Steroid Biochem Mol Biol 37:873-876.
48. Raible DW, McMorris (1990): Induction of oligodendrocyte differentiation by activator of adenyl cyclase. J Neurosci Res 27:43-46.
49. Reichel H, Koeffler HP, Norman AW (1989): The role of vitamin D endocrine system in health and disease. N Engl J Med 320: 980-991.
50. Reisman D, Elkind NB, Roy B, Beamon J, Rotter V (1993): c-Myc trans-activates the p53 promoter through a required down-stream CACGTG motif. Cell Growth Diff 4:57-65.
51. Reynolds ES (1963): The use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 17:208-216.
52. Röser K, Bonn W, Giese G, Mannweiler (1991): Subclones of C6 rat glioma cells differing in intermediate filament protein expression. Exp Cell Res 197:200-206.
53. Saporito MS, Brown ER, Hartpence KC, Wilcox HM, Vaught JL, Carswell S (1993): Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res 633:186-196.
54. Schneider J, Hofman F, Apuzzo MLJ, Hinton DR (1992): Cytokines and immunoregulatory molecules in malignant glial neoplasms. I Neurosurg 77:265-273.
55. Schräder M, Müller KM, Becker-André M, Calberg C (1993): Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 268:17830-17836.
56. Schulze-Osthoff K, Walczak H, Dröge W, Krammer PH (1994): Cell nucleus and DNA fragmentation are not required for apoptosis. J Biol Chem 127:15-20.
57. Schwartz LM, Smith SW, Jones MEE, Osborne BA (1993): Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90:980-984.
58. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF (1983): Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
59. Shabahang M, Buras RR, Davoodi F, Schumake LM, Nauta RJ, Usokovic MR, Brenner RV, Evans SRT (1994): Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res54:4057-4064.
60. Shi Y, Glynn JM, Guilbert LJ, Cotter TO, Bissonnette RP, Green DR (1992): Role of c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214.
61. Shweiki D, Itin A, Soffer D, Keshet E (1992): Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
62. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT (1989): Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181-184, 1989.
63. Sonnenberg J, Luine VN, Krey LC, Christakos S (1986): 1,25-dihydroxyvitamin D3 treatment results in increased choline acetyltransferase in specific brain nuclei. Endocrinology 118:1433-1439.
64. Stumpf WE, Madhabananda S, Clark SA (1982): Brain target sites for 1,25-dihydroxyvitamin D3. Science 215:1403-1405.
65. Stumpf WE, O'Brien LP (1987): 1,25-dihydroxyvitamin D3 sites of action in the brain: an autoradiographic study. Histochemistry 87:393-406.
66. Sutherland MK, Somerville MJ, Yoong LKK, Bergeron C, Haussler MR, McLachlan DRC (1992): Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Mol Brain Res 13:239-250.
67. Vindelov L, Christensen I, Nissen D (1983): A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327.
68. Williams GT, Smith CA (1993): Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777-779.
69. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P (1991): 1,25-dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28:110-114.
70. Woronicz JD, Calnan B, Ngo V, Winoto A (1994): Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277-281.
71. Wyllie AH, Kerr JFR, Currie AR (1980a): Cell death: the significance of apoptosis. Int Rev Cytology 68:251-306.
72. Wyllie AH (1980b): Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
73. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Zevaco M, Näär A, Kim SY, Boutin JM, Glass CK, Rosenfeld MG (1991): RXRβ: a coregulator that enhance binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
74. Zambetti GP, Levine AJ (1993): A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865.
75. Zhan Q, Bae I, Kastan MB, Fornace AJ (1994): The p53-dependent γ-ray response of GADD45. Cancer Res 54:2755-2760.